| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 15.44B | 18.01B | 19.86B | 17.73B | 13.41B |
| Gross Profit | 2.26B | 2.40B | 2.60B | 2.04B | 1.82B |
| EBITDA | 881.33M | 785.73M | 882.88M | 770.47M | 707.32M |
| Net Income | 13.36M | 206.49M | 326.25M | 312.37M | 292.62M |
Balance Sheet | |||||
| Total Assets | 8.27B | 9.26B | 9.48B | 9.56B | 8.03B |
| Cash, Cash Equivalents and Short-Term Investments | 1.09B | 1.09B | 1.11B | 1.39B | 1.79B |
| Total Debt | 2.28B | 2.28B | 2.31B | 2.34B | 2.09B |
| Total Liabilities | 5.90B | 6.09B | 6.30B | 6.59B | 5.33B |
| Stockholders Equity | 2.26B | 3.07B | 3.09B | 2.91B | 2.65B |
Cash Flow | |||||
| Free Cash Flow | 475.45M | 367.73M | 491.67M | 257.42M | 564.89M |
| Operating Cash Flow | 684.10M | 582.03M | 722.02M | 451.77M | 727.77M |
| Investing Cash Flow | 344.92M | -338.14M | -525.29M | -867.43M | -391.52M |
| Financing Cash Flow | -1.11B | -180.89M | -472.75M | 21.49M | -256.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £3.34B | 25.49 | 9.72% | 5.64% | 49.70% | -5.56% | |
69 Neutral | £4.83B | -27.21 | -4.05% | 8.77% | 57.55% | -54.80% | |
66 Neutral | £5.03B | 384.01 | 0.55% | 4.43% | -14.26% | -79.14% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | £65.72M | 12.63 | 6.02% | 6.59% | -5.21% | -33.93% | |
64 Neutral | £3.70B | 20.37 | 9.33% | 14.05% | 36.10% | ― | |
63 Neutral | £791.71M | 3.11 | 40.22% | 10.49% | ― | ― |